share_log

Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Director MYERS KENNY

Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Director MYERS KENNY

Mangoceuticals | 4:持股變動聲明-董事 MYERS KENNY
美股SEC公告 ·  06/05 17:17

Moomoo AI 已提取核心訊息

Kenny Myers, associated with Mangoceuticals, Inc. (MGRX), was granted 100,000 shares of common stock on June 3, 2024. The transaction, which was completed on the same date, was a grant of shares at no cost to Myers. Following this transaction, Myers directly holds a total of 175,000 shares in the company. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of management with those of shareholders.
Kenny Myers, associated with Mangoceuticals, Inc. (MGRX), was granted 100,000 shares of common stock on June 3, 2024. The transaction, which was completed on the same date, was a grant of shares at no cost to Myers. Following this transaction, Myers directly holds a total of 175,000 shares in the company. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of management with those of shareholders.
Kenny Myers,與Mangoceuticals,Inc. (MGRX) 相關,於2024年6月3日被授予了10萬股普通股。這筆交易於同一日期完成,是Myers無償授予股份的一部分。此次交易後,Myers直接持有該公司175,000股。這是公司股票報酬計畫的一部分,體現了將管理層的利益與股東利益相衝突的持續承諾。
Kenny Myers,與Mangoceuticals,Inc. (MGRX) 相關,於2024年6月3日被授予了10萬股普通股。這筆交易於同一日期完成,是Myers無償授予股份的一部分。此次交易後,Myers直接持有該公司175,000股。這是公司股票報酬計畫的一部分,體現了將管理層的利益與股東利益相衝突的持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息